Create a 3- to 4-page (excluding visual elements) Medication Study Guide for your assigned psychotropic medication agents that may be utilized by you and colleagues for study. Your medication guide should be in the form of an outline and should include a title page, citations, and references. You should incorporate visual elements, such as concept maps, charts, diagrams, images, color coding, mnemonics, and/or flashcards. Be creative!
Note: Your Medication Study Guide should not be in the format of an APA paper.
Also Note: Your guide should be informed by the FDA-Approved and Evidenced-Based, Clinical Practice Guidelines Research.
Areas of importance that you should address—but are not limited to—include:
· Title page
· Description of the psychopharmacological medication agent, including brand and generic names, as well as appropriate FDA indication uses
· Any supporting, valid, and reliable research for non-FDA uses
· Drug classification
· The medication mechanism of action
· The medication pharmacokinetics
· The medication pharmacodynamics
· Appropriate dosing, administration route, and any considerations for dosing alterations
· Considerations of use and dosing in specific specialty populations, such as children, adolescents, elderly, pregnant people, those exhibiting suicidal behaviors, etc.
· Definition of half-life, why half-life is important, and the half-life for your assigned medication
· Side effects/adverse reactions potential
· Discuss clinical concerns with EPS and Tardive Dyskinesia Note: Be sure to include screening tools that would be utilized.
· Contraindications for use including significant drug to drug interactions
· Overdose considerations
· Diagnostics and labs monitoring comorbidities considerations
· Legal, ethical, and social considerations
· Pertinent patient education considerations
· References page
Support your rationale with a minimum of three (3) academic resources.
Note: While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing primary and secondary literature.
Use some of these references
· Goldin, D. S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing.
· Chapter 7, “Antipsychotic Medications” (pp. 110–149)
· Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.
· Chapter 4, “Psychosis Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate” (pp. 71–158)
· Chapter 5, “Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called ‘Antipsychotics’” (pp. 159-243)
· American Psychiatric Association (2020). The American Psychiatric Association practice guideline for the treatment of patients with schizophreniaLinks to an external site. . https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/Clinical%20Practice%20Guidelines/APA-Draft-Schizophrenia-Treatment-Guideline.pdf
· Clozapine REMS (2023). What is the clozapine REMS? Links to an external site. https://www.newclozapinerems.com/home#
· Utah State University. (n.d.). Creating study guidesLinks to an external site. . https://www.usu.edu/academic-support/test/creating_study_guides
· Drugs.comLinks to an external site.. (2023). https://www.drugs.com/ Note: Please use the following resource to check the most up-to-date box warnings, FDA approvals and indications, recommendations for follow-up evaluations, changes, etc.